Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study to Evaluate Safety of Fresolimumab in Adults With Moderate-to-severe Osteogenesis Imperfecta

NCT03064074 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT03064074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03064074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study to Evaluate Safety of Fresolimumab in Adults With Moderate-to-severe Osteogenesis Imperfecta
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
November 15, 2017
Completion date
July 4, 2022
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteogenesis imperfecta